Key Developments

In April 2023, Terumo India, a subsidiary of Terumo Corporation (TSE 4543), launched a pioneering program for Cathlab Directors in partnership with Executive Education at the Indian School of Business, a top-ranked business school. The initiative aims to enhance care quality and operational efficiency in Cathlabs across India.
In July 2022, the foundation was established for the Antivenom Research and Development Centre (AVRDC) at the Institute of Bioinformatics and Applied Biotechnology (IBAB), located in Bengaluru Helix Biotech Park, Electronics City. The center aims to enhance production efforts for antivenom.
In April 2022, an additional agreement was signed under the technical cooperation agreement between Brazil and the government of the Republic of the Union of Myanmar. This agreement supports the project "Improving methodologies and techniques for the production of antivenom serum in Myanmar - phase II: antivenom quality," focusing on enhancing the quality and effectiveness of antivenom serum produced in Myanmar.
In March 2022, Smiths Medical, a renowned name in the medical equipment industry, introduced the acapella choice blue vibratory PEP therapy system. This innovative device benefits patients with conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), lung diseases involving secretion issues, and atelectasis by aiding in the clearance of lung secretions.
In August 2022, the Indian Institute of Science Labs and Bharat Serums and Vaccines (BSV), an Indian biopharmaceutical company, collaborated on advanced treatments for snake bites. Their joint efforts focus on developing cutting-edge therapies to combat the effects of snake venom.